Scientist
NIH/NCATS
Qi Zhang is a research scientist in the Therapeutic Development Branch within NCATS’ Division of Preclinical Innovation, where he studies COVID-19 viral infection and neurodegenerative diseases for therapeutics development.
Prior to joining NCATS in 2021, he completed a postdoctoral fellowship at the National Institute of Diabetes and Digestive and Kidney Diseases, where he developed research expertise in the cellular pathology of neurodegenerative and infectious diseases.